CHOO LEE: Open Payments
NPI 1649271818 · SONORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 63 payments from 18 companies in 2025. Trend: 2023 $1,169 · 2024 $1,551 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 9 | $224 |
| Biogen, Inc. | 14 | $221 |
| Alexion Pharmaceuticals, Inc. | 5 | $166 |
| PFIZER INC. | 9 | $144 |
| EMD Serono, Inc. | 3 | $143 |
| ARGENX US, INC. | 3 | $83 |
| Lilly USA, LLC | 3 | $81 |
| UCB, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Genentech USA, Inc. | 2 | $55 |
Products named: Leqembi, ULTOMIRIS, NURTEC ODT, KISUNLA, TYSABRI, HETLIOZ, VYVGART, Ocrevus Zunovo.
Industry payments across CA — which companies pay providers there.
